Opaleye Management Inc.

10% OwnerTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed Jan 24, 2022
Net Buying
Open-Market Buys
$112K
Open-Market Sells
$0
Net Open-Market Flow
$112K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 24, 2022Buy(P)2K$2.05$5K317K
Jan 24, 2022Buy(P)15K$2.05$31K2.8M
Jan 21, 2022Buy(P)30K$2.19$66K2.8M
Jan 21, 2022Buy(P)5K$2.19$11K315K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-002142) within minutes of acceptance. Every field above traces to the original document. Verify it directly: